GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of EUR 64.91 billion. The enterprise value is 80.25 billion.
Market Cap | 64.91B |
Enterprise Value | 80.25B |
Important Dates
The last earnings date was Monday, July 28, 2025.
Earnings Date | Jul 28, 2025 |
Ex-Dividend Date | May 15, 2025 |
Share Statistics
Current Share Class | 4.03B |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.49% |
Shares Change (QoQ) | -0.65% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 3.90B |
Valuation Ratios
The trailing PE ratio is 16.26 and the forward PE ratio is 8.45.
PE Ratio | 16.26 |
Forward PE | 8.45 |
PS Ratio | 1.76 |
PB Ratio | 3.88 |
P/TBV Ratio | n/a |
P/FCF Ratio | 8.68 |
P/OCF Ratio | 7.20 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.33, with an EV/FCF ratio of 10.73.
EV / Earnings | 20.10 |
EV / Sales | 2.20 |
EV / EBITDA | 7.33 |
EV / EBIT | 10.93 |
EV / FCF | 10.73 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.21.
Current Ratio | 0.87 |
Quick Ratio | 0.56 |
Debt / Equity | 1.21 |
Debt / EBITDA | 1.83 |
Debt / FCF | 2.71 |
Interest Coverage | 10.25 |
Financial Efficiency
Return on equity (ROE) is 28.33% and return on invested capital (ROIC) is 12.75%.
Return on Equity (ROE) | 28.33% |
Return on Assets (ROA) | 6.78% |
Return on Invested Capital (ROIC) | 12.75% |
Return on Capital Employed (ROCE) | 16.38% |
Revenue Per Employee | 537,683 |
Profits Per Employee | 58,186 |
Employee Count | 68,629 |
Asset Turnover | 0.54 |
Inventory Turnover | 1.50 |
Taxes
In the past 12 months, GSK plc has paid 744.29 million in taxes.
Income Tax | 744.29M |
Effective Tax Rate | 13.80% |
Stock Price Statistics
The stock price has decreased by -9.58% in the last 52 weeks. The beta is 0.27, so GSK plc's price volatility has been lower than the market average.
Beta (5Y) | 0.27 |
52-Week Price Change | -9.58% |
50-Day Moving Average | 16.71 |
200-Day Moving Average | 16.83 |
Relative Strength Index (RSI) | 48.61 |
Average Volume (20 Days) | 569,858 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of EUR 36.90 billion and earned 3.99 billion in profits. Earnings per share was 0.96.
Revenue | 36.90B |
Gross Profit | 26.45B |
Operating Income | 7.43B |
Pretax Income | 5.39B |
Net Income | 3.99B |
EBITDA | 10.84B |
EBIT | 7.43B |
Earnings Per Share (EPS) | 0.96 |
Balance Sheet
The company has 4.22 billion in cash and 20.25 billion in debt, giving a net cash position of -16.02 billion.
Cash & Cash Equivalents | 4.22B |
Total Debt | 20.25B |
Net Cash | -16.02B |
Net Cash Per Share | n/a |
Equity (Book Value) | 16.75B |
Book Value Per Share | 4.26 |
Working Capital | -3.16B |
Cash Flow
In the last 12 months, operating cash flow was 9.01 billion and capital expenditures -1.53 billion, giving a free cash flow of 7.48 billion.
Operating Cash Flow | 9.01B |
Capital Expenditures | -1.53B |
Free Cash Flow | 7.48B |
FCF Per Share | n/a |
Margins
Gross margin is 71.69%, with operating and profit margins of 20.13% and 10.82%.
Gross Margin | 71.69% |
Operating Margin | 20.13% |
Pretax Margin | 14.61% |
Profit Margin | 10.82% |
EBITDA Margin | 29.37% |
EBIT Margin | 20.13% |
FCF Margin | 20.27% |
Dividends & Yields
This stock pays an annual dividend of 0.74, which amounts to a dividend yield of 4.56%.
Dividend Per Share | 0.74 |
Dividend Yield | 4.56% |
Dividend Growth (YoY) | 7.68% |
Years of Dividend Growth | 1 |
Payout Ratio | 72.80% |
Buyback Yield | -0.49% |
Shareholder Yield | 4.08% |
Earnings Yield | 6.15% |
FCF Yield | 11.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
Last Split Date | Jul 19, 2022 |
Split Type | Reverse |
Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 1.83 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.83 |
Piotroski F-Score | 6 |